Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-mediated gene silencing is a fundamental biological process involving small non-coding RNAs (miRNAs) that regulate gene expression at the post-transcriptional level. miRNAs, typically 19-25 nucleotides long, bind to target messenger RNAs (mRNAs) leading to their translational repression or degradation. This intricate regulatory mechanism plays crucial roles in various cellular processes, including development, differentiation, metabolism, and stress responses. Dysregulation of miRNA-mediated gene silencing is implicated in numerous diseases, making miRNAs and their regulatory pathways potential targets for therapeutic intervention or diagnostic biomarkers.
Translational repression of mRNAs via miRNA-loaded RISCs; Induction of mRNA degradation through deadenylation and decapping; AGO2-mediated endonucleolytic cleavage (rare in animals, more common in plants).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-mediated gene silencing.